Roflumilast and Donepezil to Reverse Scopolamine Induced Cognitive Deficits in Healthy Adults
Clinical trial NCT02051335 · COMPLETED
Trial details
- NCT number
- NCT02051335
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-01
- Primary completion
- 2014-05-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.